Value of detection of antibodies to Candida albicans germ tube in the diagnosis of systemic candidosis

Eur J Clin Microbiol Infect Dis. 1990 Mar;9(3):178-83. doi: 10.1007/BF01963834.


To test the value of detection of anti-Candida albicans germ tube antibodies by indirect immunofluorescence assay in the diagnosis of systemic candidosis, a retrospective study was done using 126 sera from 27 patients with presumptive systemic candidosis (13 immunocompromised), 165 sera from 45 patients with aspergillosis (29 immunocompromised), 35 sera from eight patients with cryptococcosis (6 immunocompromised), and 101 sera from 101 blood donors. While 21 of 27 patients with systemic candidosis (77.8%) had anti-germ tube antibodies, these antibodies were absent in all patients with cryptococcosis and in all blood donors. They were however detected in 5 of 45 patients with aspergillosis (11.1%). Ten of 13 (76.9%) immunocompromised patients with candidosis had anti-germ tube antibodies; similar results were obtained in immunocompetent patients with candidosis (78.6%). The specificity was 96.8%, indicating a high degree of discrimination was possible between systemic candidosis and other invasive mycoses in the patients studied. Anti-germ tube responses did not appear to be significantly reduced in immunocompromised patients.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Fungal / isolation & purification*
  • Aspergillosis / diagnosis
  • Aspergillosis / immunology
  • Candida albicans / growth & development
  • Candida albicans / immunology*
  • Candidiasis / diagnosis*
  • Candidiasis / immunology
  • Cryptococcosis / diagnosis
  • Cryptococcosis / immunology
  • Diagnosis, Differential
  • Evaluation Studies as Topic
  • Humans
  • Immunocompetence
  • Serologic Tests


  • Antibodies, Fungal